|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/05 | |
| A61P 35/00 |
| (11) | Patento numeris | 3160455 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15733502.7 |
| Europos patento paraiškos padavimo data | 2015-06-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2015/051876 |
| Data | 2015-06-26 |
| (87) | Numeris | WO 2015/198071 |
| Data | 2015-12-30 |
| (30) | Numeris | Data | Šalis |
| 201411465 | 2014-06-27 | GB |
| (72) |
STOTT, Colin, GB
DUNCAN, Marnie, GB
HILL, Thomas, GB
|
| (73) |
GW Research Limited,
Sovereign House, Vision Park Histon, Cambridge, CB24 9BZ,
GB
|
| (54) | ACTIVE PHARMACEUTICAL INGREDIENT (API) COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF CANCER |
| ACTIVE PHARMACEUTICAL INGREDIENT (API) COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF CANCER |